tiprankstipranks
Trending News
More News >
Pharming Group (PHAR)
NASDAQ:PHAR
US Market
Advertisement

Pharming Group (PHAR) Technical Analysis

Compare
148 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
4Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Pharming Group’s (PHAR) Moving Averages Convergence Divergence (MACD) indicator is 0.70, suggesting Pharming Group is a Sell.
Pharming Group’s (PHAR) 20-Day exponential moving average is 12.25, while Pharming Group’s (PHAR) share price is $13.4, making it a Buy.
Pharming Group’s (PHAR) 50-Day exponential moving average is 11.39, while Pharming Group’s (PHAR) share price is $13.4, making it a Buy.

Pharming Group (PHAR) Pivot Points

Aug 27, 2025, 09:06 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.66
13.18
13.73
14.25
14.80
15.32
15.87
Fibonacci
13.18
13.59
13.84
14.25
14.66
14.91
15.32
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharming Group (PHAR) Moving Averages

Aug 27, 2025, 09:06 PM
Period
Simple
Exponential
MA5
13.25Buy
13.32Buy
MA10
12.55Buy
12.85Buy
MA20
12.17Buy
12.25Buy
MA50
11.12Buy
11.39Buy
MA100
10.34Buy
10.65Buy
MA200
9.55Buy
9.75Buy
Pharming Group’s (PHAR) 10-Day exponential moving average is 12.85, while Pharming Group’s (PHAR) share price is $13.4, making it a Buy.
Pharming Group’s (PHAR) 100-Day exponential moving average is 10.65, while Pharming Group’s (PHAR) share price is $13.4, making it a Buy.
Pharming Group’s (PHAR) stock price is $13.4 and Pharming Group’s (PHAR) 50-day simple moving average is 11.12, creating a Buy signal.
Pharming Group’s (PHAR) stock price is $13.4 and Pharming Group’s (PHAR) 100-day simple moving average is 10.34, creating a Buy signal.
Pharming Group’s (PHAR) stock price is $13.4 and Pharming Group’s (PHAR) 200-day simple moving average is 9.55, creating a Buy signal.

Pharming Group (PHAR) Technical Indicators

Aug 27, 2025, 09:06 PM
Name
Value
Implied Action
RSI (14)
61.21
Neutral
STOCH (9,6)
81.43
Sell
STOCHRSI (14)
45.94
Neutral
MACD (12,26)
0.70
Sell
ADX (14)
41.24
Neutral
Williams %R
-60.53
Buy
CCI (14)
107.25
Sell
ATR (14)
0.86
-
Ultimate Oscillator
51.60
Neutral
ROC
9.03
Buy
Pharming Group’s (PHAR) Relative Strength Index (RSI) is 61.21, creating a Neutral signal.
Pharming Group’s (PHAR) Trend Strength Indicator (ADX) is 41.24, creating a Neutral signal.
Pharming Group’s (PHAR) Commodity Channel Index (CCI) is 107.25, creating a Sell signal.
Pharming Group’s (PHAR) Price Rate of Change (ROC) is 9.03, creating a Buy signal.

FAQ

Is PHAR a Buy, Hold, or Sell?
Based on PHAR’s technical indicators, PHAR is a Strong Buy.
    What is PHAR’s RSI (14)?
    PHAR’s RSI (14) is 61.21, which suggests PHAR is a Neutral.
      What is PHAR’s MACD?
      PHAR’s MACD is 0.70, which suggests PHAR is a Sell.
        What is PHAR’s 5-day moving average?
        PHAR’s 5-day moving average is 13.25, which suggests PHAR is a Buy.
          What is PHAR’s 20-day moving average?
          PHAR 20-day moving average is 12.17, which suggests PHAR is a Buy.
            What is PHAR’s 50-day moving average?
            PHAR’s 50-day moving average is 11.12, which suggests PHAR is a Buy.
              What is PHAR’s 200-day moving average?
              PHAR’s 200-day moving average is 9.55, which suggests PHAR is a Buy.
                What is PHAR’s Williams % R (14)?
                PHAR’s Williams % R (14) is -60.53, which suggests PHAR is a Buy.
                  What is PHAR’s CCI (14)?
                  PHAR’s CCI (14) is 107.25, which suggests PHAR is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis